Trending Stories


From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.

MedAxiom Announces Industry Partnership With Cell>Point

Partner News | Published: Monday, June 1, 2020

Cell>Point, LLC. is a leader in the development and commercialization of molecular imaging and targeted therapeutics.


The Benefits of a Sale-Leaseback Real Estate Transaction

Partner News | Published: Wednesday, May 20, 2020

Many factors influence your decision to execute a sale-leaseback of your building, including deal terms, asset location, strength of the practice, and tenure of the physicians. In this white paper from Physicians Realty Trust, a trusted industry partner, learn what factors to consider as you determine if the timing is right to look at a potential sale-leaseback for your real estate.


Cardiac imaging company Genetesis adds TDK Ventures as strategic investor

Partner News | Published: Wednesday, May 13, 2020

Genetesis Inc, a MedAxiom partner and medical technology company that has developed non-invasive, biomagnetic CardioFlux™ imaging, has announced several important updates. The company has closed

Keeping Your Patient Appointment Schedule Intact During (and After) the COVID-19 Pandemic

Partner News | Published: Monday, May 11, 2020

Medical practices are working through multiple issues brought on by the COVID-19 pandemic: supplying needed care for patients, uncertainties in staffing, PPE supply, PPP funding, and preserving revenue. Some

Farxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction

Partner News | Published: Thursday, May 7, 2020

AstraZeneca’s Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure in adults with heart failure (NYHA class II-IV)

A FAST, COMPREHENSIVE APPROACH FOR RE-OPENING YOUR CV SERVICE LINE

Partner News | Published: Monday, May 4, 2020

As we emerge from the unprecedented COVID-19 crisis, programs across the country are seeking a safe, rational approach to re-opening their Cath Labs and resuming elective revascularization. MedAxiom Industry

TDK Ventures Invests in Biomagnetic Medical Imaging Company Genetesis

Partner News | Published: Wednesday, April 29, 2020

TDK Corporation (TSE:6762) announces that subsidiary TDK Ventures Inc. adds to its growing portfolio of companies with an investment in Genetesis, a world leader in non-invasive biomagnetic imaging. Genetesis

CARDIAC PET/CT MPI – Preparing your nuclear cardiac imaging lab during uncertain times

Partner News | Published: Wednesday, April 29, 2020

COVID-19, or the Coronavirus, has been the source of widespread concern across the country. This is a severe illness for those with a compromised immune system such as the elderly or those with preexisting

ENSURE YOUR EHR DATA IS ENGAGED CORRECTLY FOR TELEMEDICINE AND BEYOND

Partner News | Published: Thursday, April 23, 2020

COVID-19 is pushing the rapid adoption of virtual visits and telemedicine connectivity in order to treat both new and existing patients. It is vital that providers have historical health information for each

MedAxiom Industry Partner Solutions to Help Navigate COVID-19

Partner News | Published: Wednesday, April 22, 2020

The COVID-19 outbreak has escalated the need for innovative solutions to ensure high quality CV care can continue to be delivered to patients during this global pandemic. As a result of the COVID-19 outbreak, telehealth and virtual care delivery have emerged as invaluable tools for ensuring continuity of care.